The Role of AI Solutions in Accelerating Lung Cancer Diagnosis

Lung cancer is a major health concern, with early diagnosis being a key focus in medical interventions. Given the advancement of technology, AI solutions like Coreline Soft’s ‘AVIEW LCS’ are revolutionizing lung cancer screenings. Launched as part of South Korea’s national program, this AI-driven initiative aims to boost early diagnosis and survival rates, bridging the gap between detection and patient outcomes.

Why Lung Cancer Needs Early Detection

Lung cancer remains the leading cause of cancer-related death worldwide. According to 2023 national statistics, it accounts for 21.9% of all cancer mortalities in South Korea.
Several factors contribute to this:

• Difficulty in early detection, with most cases discovered in stages 3 or 4.
• Limited symptoms at early stages, causing delayed diagnosis.
• Smoking as a primary risk factor, though non-smokers can be affected as well.

National Lung Cancer Screening Program

In 2019, South Korea initiated the first global national lung cancer screening program. This aligns with World Cancer Day’s objectives, organized by the WHO and UICC.

Achievements and Impact

• Screening sensitivity surpassed 80%.
• Significant survival rate improvement noted among screened individuals.
• Distinct mortality rate difference between screened and non-screened groups.

AI Solution: Coreline Soft’s ‘AVIEW LCS’

This AI solution enhances the screening process by offering comprehensive testing through simple CT scans. Key aspects of AVIEW LCS include:

• Ability to identify three major smoking-related diseases: lung cancer, emphysema, and coronary artery calcification.
• High accuracy levels, with a 25% improvement over other methods, as reported in a Nature-affiliated journal.

International Adoption and Support

Several countries now push for AI in medical diagnostics. Germany, with its HANSE project, officially endorsed AI in lung cancer screenings:

• July 1, last year, marked the legislative integration of AI in medical imaging.
• AI technology boosts diagnostic accuracy and operational efficiency in healthcare.

Comments From Experts

Professor Jeong Won-ki, from Hwasun Chonnam National University Hospital, states:

• A notable shift to quality over quantity in screenings.
• Inclusion of family history and environmental factors in high-risk categories.
• AI critical for detecting complex chest CT anomalies efficiently.
• AI-driven digital data management improves resource allocation.

Conclusion

AI technologies like Coreline Soft’s ‘AVIEW LCS’ hold promise for transforming lung cancer detection. Their integration into national programs underlines a trend towards precision medicine, emphasizing not just quantity but quality in healthcare. Adoption of such technology ensures better health outcomes and sets a benchmark for future innovations in medical AI applications.